Sponsored Links
| Stemedica Completes Meeting With The FDA |
 |
 |
 |
| Pharmacy - Pharma Industry - Biotech Industry | |||
|
Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it completed its pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a proposed IND (Investigative New Drug) to evaluate the safety and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke. Read more: Pharma Industry / Biotech Industry News From Medical News Today
|